Another bumper week across the sector, I have a feeling that some investors may see multiple returns on their investments when the markets turn, so many basement bargain stocks around,
Another bumper week across the sector, I have a feeling that some investors may see multiple returns on their investments when the markets turn, so many basement bargain stocks around,
After being hit hard by Western sanctions, a London-listed Russian miner has been forced to go bankrupt.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  FTSE 100, Bitcoin, Amur, DeepVerge, DigitalBox,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is  Boston, Drumz, Empire, Genedrive, Keras, Live,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is African Pioneer, Blackbird, Genedrive, i-nexus, Light
Petropavlovsk PLC (“Petropavlovsk” or the “Company” or, together with its subsidiaries, the “Group”) today issues its sales and production results and corporate update for the quarter ending 31 March 2022
ECR Minerals (ECR), the gold exploration and development company, updated on drilling at HR3 including the highest grade Gold intercept yet below the soil anomaly drilled by hole BH3DD027. @ZaksTradersCafe
Petropavlovsk PLC (“Petropavlovsk” or the “Company” and, together with its subsidiaries, the “Group”) provides a further update in relation to Gazprombank (“GPB”).
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Amte, Bisichi, Chariot, Eurasia, Gunsynd, Itaconix, JP Morgan
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Argo, Audioboom, Chariot, DeepVerge, Eurasia, Emmerson, Harvest, Kefi,
Open Orphan (ORPH), a rapidly growing specialist contract research organisation announces is growing yet further. hVIVO, a subsidiary of Open Orphan, has signed a £5m respiratory syncytial virus human challenge